16:27 |
171.00p |
2 |
£3 |
Sell |
O |
11:28 |
175.87p |
120 |
£211 |
Buy |
O |
10:12 |
170.00p |
5 |
£8 |
Sell |
O |
10:12 |
171.00p |
5,485 |
£9,379 |
Sell |
AT |
10:12 |
171.00p |
5,500 |
£9,405 |
Sell |
O |
10:04 |
180.00p |
1 |
£2 |
Buy |
O |
10:04 |
180.00p |
9 |
£16 |
Buy |
O |
10:04 |
180.00p |
1 |
£2 |
Buy |
O |
10:04 |
180.00p |
11 |
£20 |
Buy |
O |
10:04 |
180.00p |
2 |
£4 |
Buy |
O |
09:01 |
171.90p |
1,737 |
£2,986 |
Sell |
O |
08:48 |
171.09p |
3,422 |
£5,855 |
Sell |
O |
08:28 |
171.90p |
600 |
£1,031 |
Sell |
O |
|
Final |
Interim |
Ex-Div |
24-Apr-25 |
10-Oct-24 |
Paid |
27-May-25 |
25-Oct-24 |
Amount |
4.81p |
2.98p |
16:27 |
2 @ 171.00p |
14:44 |
2,826 @ 175.86p |
11:28 |
120 @ 175.87p |
10:12 |
5 @ 170.00p |
10:12 |
5,485 @ 171.00p |
Chair |
Robert Ellis |
CEO |
Trevor Harvey |
CFO |
Leigh Wilcox |
Top of Page
You are here:
research